Drug Database
Back to search

Switzerland· 53090028

Campral

A acamprosate product containing acamprosatum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC N07BB03

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedCampralATCN07BB03REGISTER NO.53090028PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acamprosatumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acamprosate is registered in 14 of 19 countries.

Countries holding a registration under ATC N07BB03 (acamprosate), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search acamprosate products by name

Acamprosate · ATC N07BB03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acamprosate costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.14 in France to $3.37 in Switzerland — a ×3.0 gap.

  • Switzerland: $3.37 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acamprosate · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.37
  • IT Italy$2.75
  • FR France$1.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
acamprosatum
Manufacturer
—
Country
Switzerland (CH)
ATC code
N07BB03
ATC class
Acamprosate
Defined daily dose
2 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680530900280
    84 Stk
    CHF 40

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for acamprosate.

Graded by severity as the source publishes them — 19 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acamprosate against other medicinesHow interaction checks work

Acamprosate · interactions on record

19 records

  • 19 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Acamprosate in 13 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All acamprosate products

    Authorised across Europe · EMA

    The same active substance is authorised in 16 EEA countries. Names it is sold under:

    • Austria · Campral
    • Belgium · Campral
    • Czechia · Campral
    • Germany · Campral
    • Spain · Campral
    • France · Acamprosate Biogaran, Acamprosate Viatris
    • United Kingdom (Northern Ireland) · Acamprosate Generics [uk] Ltd, Acamprosate Strandhaven Somex Pharma
    • Ireland · Campral Ec
    • Italy · Campral
    • Luxembourg · Campral
    • Netherlands · Campral
    • Norway · Campral
    • Poland · Campral
    • Portugal · Campral
    • Sweden · Akamprosat Viatris, Campral
    • Slovakia · Acamprosat Viatris, Campral

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/7b729999-cb59-4f3a-9ffc-7db7dd4570c3
GET /v1/drugs/7b729999-cb59-4f3a-9ffc-7db7dd4570c3?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "unit": null,
  "strength": "acamprosatum 300 mg",
  "valid_from": "1997-03-15",
  "limitations": "[{\"description\":\"Behandlung ist beschränkt auf 1 Jahr.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2007-01-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 300 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1997-03-15",
  "self_retention_pct": 10
}
    API referenceMCP serverPlans

    See everything about acamprosate.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console